NCT03125226View on ClinicalTrials.gov

TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 5, 2017

Primary Completion Date

January 1, 2020

Study Completion Date

May 18, 2020

Conditions
Bladder Carcinoma
Interventions
DEVICE

Polyethylene Glycol Hydrogel

Given TracelT hydrogel via injection

Trial Locations (1)

98109

Fred Hutch/University of Washington Cancer Consortium, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Washington

OTHER

NCT03125226 - TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer | Biotech Hunter | Biotech Hunter